• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

燃料对肌肉磷酸甘油酸变位酶缺乏症患者运动能力的影响。

Effect of fuels on exercise capacity in muscle phosphoglycerate mutase deficiency.

作者信息

Vissing John, Quistorff Bjørn, Haller Ronald G

机构信息

Copenhagen Muscle Research Center, National University Hospital, Denmark.

出版信息

Arch Neurol. 2005 Sep;62(9):1440-3. doi: 10.1001/archneur.62.9.1440.

DOI:10.1001/archneur.62.9.1440
PMID:16157752
Abstract

BACKGROUND

Muscle phosphoglycerate mutase deficiency (PGAMD) is a rare, recessively inherited metabolic myopathy that affects one of the last steps of glycolysis. Clinically, PGAMD resembles muscle phosphorylase deficiency (McArdle disease) and phosphofructokinase deficiency (PFKD). However, it is unknown whether PGAMD is associated with a second-wind phenomenon during exercise, as in McArdle disease, and whether patients with PGAMD, like patients with PFKD and McArdle disease, benefit from supplementation with fuels that bypass the metabolic block.

OBJECTIVE

To investigate whether fuels that bypass the metabolic block can improve exercise capacity or whether exercise capacity improves during sustained exercise.

DESIGN

Single-blind, placebo-controlled investigation of the effects of glucose, lactate, and intralipid on work capacity in patients with PGAMD.

SETTING

National University Hospital, University of Copenhagen, and Neuromuscular Center, Institute for Exercise and Environmental Medicine. Patients Two unrelated men (21 and 26 years old) with PGAMD who since their teens had experienced muscle cramps, muscle pain, and episodes of myoglobinuria provoked by brief vigorous exercise, 4 patients with McArdle disease (mean +/- SD age, 32 +/- 5 years) with 0% residual phosphorylase activity in muscle, and 6 healthy, untrained male volunteers (mean +/- SD age, 23 +/- 1 years) were studied.

INTERVENTIONS

Using constant and variable workload protocols on a cycle ergometer, it was investigated whether a spontaneous second wind occurs during exercise in patients with PGAMD, and using a constant workload protocol followed by an incremental load to exhaustion, it was tested whether infusion of lactate, glucose, or intralipid alters the exercise tolerance in PGAMD.

MAIN OUTCOME MEASURES

Whether a second wind occurs during exercise and whether fuels that bypass the metabolic block can improve exercise and oxidative capacity.

RESULTS

In contrast to patients with McArdle disease, with whom they share many clinical features, in patients with PGAMD, cycle exercise and oxidative capacity are virtually normal, a second wind does not occur, and lipid and lactate supplements do not improve exercise capacity.

CONCLUSION

Although the clinical manifestations of PGAMD mimic McArdle disease with respect to the presence of exertional muscle cramps, rhabdomyolysis, and myoglobinuria, this study shows that cycle exercise responses are strikingly different.

摘要

背景

肌肉磷酸甘油酸变位酶缺乏症(PGAMD)是一种罕见的隐性遗传代谢性肌病,影响糖酵解的最后步骤之一。临床上,PGAMD类似于肌肉磷酸化酶缺乏症(麦克尔迪氏病)和磷酸果糖激酶缺乏症(PFKD)。然而,尚不清楚PGAMD是否像麦克尔迪氏病那样在运动期间与第二次呼吸现象有关,以及PGAMD患者是否像PFKD和麦克尔迪氏病患者一样能从补充绕过代谢障碍的燃料中获益。

目的

研究绕过代谢障碍的燃料是否能提高运动能力,或者持续运动期间运动能力是否会提高。

设计

对葡萄糖、乳酸和脂肪乳对PGAMD患者工作能力影响的单盲、安慰剂对照研究。

地点

哥本哈根大学国立大学医院以及运动与环境医学研究所神经肌肉中心。患者:两名患有PGAMD的无血缘关系男性(分别为21岁和26岁),自青少年时期起就经历过因短暂剧烈运动引发的肌肉痉挛、肌肉疼痛和肌红蛋白尿发作;4名麦克尔迪氏病患者(平均年龄±标准差为32±5岁),肌肉中磷酸化酶活性残余为0%;以及6名健康的未经训练的男性志愿者(平均年龄±标准差为23±1岁)参与了研究。

干预措施

在自行车测力计上采用恒定和可变工作量方案,研究PGAMD患者运动期间是否会出现自发的第二次呼吸现象;采用恒定工作量方案,随后进行递增负荷直至疲劳,测试输注乳酸、葡萄糖或脂肪乳是否会改变PGAMD患者的运动耐力。

主要观察指标

运动期间是否出现第二次呼吸现象,以及绕过代谢障碍的燃料是否能提高运动和氧化能力。

结果

与具有许多临床特征相同的麦克尔迪氏病患者不同,PGAMD患者的循环运动和氧化能力基本正常,不会出现第二次呼吸现象,脂质和乳酸补充剂也不会提高运动能力。

结论

尽管PGAMD在运动性肌肉痉挛、横纹肌溶解和肌红蛋白尿方面的临床表现与麦克尔迪氏病相似,但本研究表明循环运动反应截然不同。

相似文献

1
Effect of fuels on exercise capacity in muscle phosphoglycerate mutase deficiency.燃料对肌肉磷酸甘油酸变位酶缺乏症患者运动能力的影响。
Arch Neurol. 2005 Sep;62(9):1440-3. doi: 10.1001/archneur.62.9.1440.
2
Spontaneous "second wind" and glucose-induced second "second wind" in McArdle disease: oxidative mechanisms.麦克尔迪氏病中的自发“第二次呼吸”及葡萄糖诱导的第二次“第二次呼吸”:氧化机制
Arch Neurol. 2002 Sep;59(9):1395-402. doi: 10.1001/archneur.59.9.1395.
3
Effect of changes in fat availability on exercise capacity in McArdle disease.脂肪可利用性变化对麦克尔迪氏病运动能力的影响。
Arch Neurol. 2009 Jun;66(6):762-6. doi: 10.1001/archneurol.2009.93.
4
Fat and carbohydrate metabolism during exercise in phosphoglucomutase type 1 deficiency.磷酸葡萄糖变位酶 1 缺乏症患者运动时的脂肪和碳水化合物代谢。
J Clin Endocrinol Metab. 2013 Jul;98(7):E1235-40. doi: 10.1210/jc.2013-1651. Epub 2013 Jun 18.
5
No spontaneous second wind in muscle phosphofructokinase deficiency.肌肉磷酸果糖激酶缺乏症无自发的二次呼吸现象。
Neurology. 2004 Jan 13;62(1):82-6. doi: 10.1212/wnl.62.1.82.
6
Is muscle glycogenolysis impaired in X-linked phosphorylase b kinase deficiency?在X连锁磷酸化酶b激酶缺乏症中,肌肉糖原分解是否受损?
Neurology. 2008 May 13;70(20):1876-82. doi: 10.1212/01.wnl.0000289190.66955.67. Epub 2008 Apr 9.
7
Muscle phosphoglycerate mutase deficiency with tubular aggregates: effect of dantrolene.伴有管状聚集物的肌肉磷酸甘油酸变位酶缺乏症:丹曲林的作用。
Ann Neurol. 1999 Aug;46(2):274-7.
8
Impaired glycogen breakdown and synthesis in phosphoglucomutase 1 deficiency.磷酸葡糖变位酶 1 缺乏症中糖原分解和合成受损。
Mol Genet Metab. 2017 Nov;122(3):117-121. doi: 10.1016/j.ymgme.2017.08.007. Epub 2017 Aug 25.
9
A nonischemic forearm exercise test for McArdle disease.用于麦克尔迪氏病的非缺血性前臂运动试验。
Ann Neurol. 2002 Aug;52(2):153-9. doi: 10.1002/ana.10263.
10
Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle disease.剪接突变保留了肌磷酸化酶活性,改善了麦克尔迪氏病的表型。
Brain. 2009 Jun;132(Pt 6):1545-52. doi: 10.1093/brain/awp065. Epub 2009 May 11.

引用本文的文献

1
Recurrent Myalgia, Dark Urine, and Exercise Intolerance: Glycogen Storage Disease Type X Diagnosed Through Gene Sequencing Panel.复发性肌痛、深色尿液与运动不耐受:通过基因测序panel诊断的X型糖原贮积病
Cureus. 2024 Sep 25;16(9):e70175. doi: 10.7759/cureus.70175. eCollection 2024 Sep.
2
Energy metabolism during exercise in patients with β-enolase deficiency (GSDXIII).β-烯醇化酶缺乏症(糖原贮积病XIII型)患者运动期间的能量代谢
JIMD Rep. 2021 Jun 14;61(1):60-66. doi: 10.1002/jmd2.12232. eCollection 2021 Sep.
3
Preclinical Research in Glycogen Storage Diseases: A Comprehensive Review of Current Animal Models.
糖原贮积病的临床前研究:当前动物模型的综合综述。
Int J Mol Sci. 2020 Dec 17;21(24):9621. doi: 10.3390/ijms21249621.
4
Non-traumatic and non-drug-induced rhabdomyolysis.非创伤性和非药物性诱导的横纹肌溶解症。
Arch Med Sci Atheroscler Dis. 2019 Dec 2;4:e252-e263. doi: 10.5114/amsad.2019.90152. eCollection 2019.
5
Glycogen metabolism and glycogen storage disorders.糖原代谢与糖原贮积症
Ann Transl Med. 2018 Dec;6(24):474. doi: 10.21037/atm.2018.10.59.
6
Myopathies Related to Glycogen Metabolism Disorders.与糖原代谢紊乱相关的肌病。
Neurotherapeutics. 2018 Oct;15(4):915-927. doi: 10.1007/s13311-018-00684-2.
7
Novel heterozygous mutations in the gene with negative exercise testing.运动试验阴性的该基因中的新型杂合突变。
Mol Genet Metab Rep. 2018 Oct 9;17:53-55. doi: 10.1016/j.ymgmr.2018.09.009. eCollection 2018 Dec.
8
Treatment Opportunities in Patients With Metabolic Myopathies.代谢性肌病患者的治疗机会
Curr Treat Options Neurol. 2017 Sep 21;19(11):37. doi: 10.1007/s11940-017-0473-2.
9
Rhabdomyolysis: a genetic perspective.横纹肌溶解症:遗传学视角
Orphanet J Rare Dis. 2015 May 2;10:51. doi: 10.1186/s13023-015-0264-3.
10
Diagnostic evaluation of rhabdomyolysis.横纹肌溶解症的诊断评估。
Muscle Nerve. 2015 Jun;51(6):793-810. doi: 10.1002/mus.24606. Epub 2015 Mar 14.